2020
Immune Checkpoint Inhibitor–Induced Upper Gastrointestinal Tract Inflammation Shows Morphologic Similarities to, but Is Immunologically Distinct From, Helicobacter pylori Gastritis and Celiac Disease
Irshaid L, Robert ME, Zhang X. Immune Checkpoint Inhibitor–Induced Upper Gastrointestinal Tract Inflammation Shows Morphologic Similarities to, but Is Immunologically Distinct From, Helicobacter pylori Gastritis and Celiac Disease. Archives Of Pathology & Laboratory Medicine 2020, 145: 191-200. PMID: 33501492, DOI: 10.5858/arpa.2019-0700-oa.Peer-Reviewed Original ResearchConceptsHelicobacter pylori gastritisUpper gastrointestinal tractCeliac diseasePylori gastritisCPI therapyCD8 ratioDuodenal biopsiesInflammatory changesLymphoid aggregatesGastrointestinal tractAnti-programmed death receptor-1/Anti-cytotoxic T-lymphocyteDeath receptor-1/Immune checkpoint inhibitor therapyImmune-related adverse eventsDeath ligand 1 antibodyColonic mucosal changesGastrointestinal tract inflammationLamina propria CD3Lamina propria inflammationUpper gastrointestinal biopsiesUpper gastrointestinal injuryCheckpoint inhibitor therapyH pylori gastritisCD8 T cells
1993
HELICOBACTER PYLORI–ASSOCIATED GASTRIC PATHOLOGY
Robert M, Weinstein W. HELICOBACTER PYLORI–ASSOCIATED GASTRIC PATHOLOGY. Gastroenterology Clinics Of North America 1993, 22: 59-72. PMID: 8449571, DOI: 10.1016/s0889-8553(21)00263-6.Peer-Reviewed Original ResearchMeSH KeywordsGastric MucosaGastritisHelicobacter InfectionsHelicobacter pyloriHumansMetaplasiaStomach DiseasesConceptsH. pylori gastritisIntestinal metaplasiaPylori gastritisH. pyloriDuodenal ulcer relapseChronic active gastritisCommon histologic patternSevere atrophic gastritisDiffuse intestinal metaplasiaUlcer relapseActive gastritisAtrophic gastritisBody mucosaHistologic patternNonspecific gastritisClinical managementCommon causeIndividual patientsGastric pathologyGastritisPyloriMetaplasiaAntrumLimited valueResearch studies